![](/sites/default/files/styles/article_actu_main_image/public/2024-03/EAHP.png?itok=vJ7rEfYV)
Provepharm will attend the EAHP (European Association of Hospital Pharmacists) congress in Bordeaux 20th to 22th of March 2024.
![](/sites/default/files/styles/article_actu_main_image/public/2024-03/EAHP.png?itok=vJ7rEfYV)
Provepharm will attend the EAHP (European Association of Hospital Pharmacists) congress in Bordeaux 20th to 22th of March 2024.
![](/sites/default/files/styles/article_actu_main_image/public/2022-07/Banni%C3%A8re-vide-nouvelle-identit%C3%A9-bleue.jpg?itok=RuCO4wgg)
All Provepharm employees wish you happy holidays and All the Best for 2024.
Discover our wishes in video!
![](/sites/default/files/styles/article_actu_main_image/public/2023-09/actu-malaisie.jpg?itok=6JGZzXaH)
Company joins exclusive club of pioneering B Corp-certified pharmaceutical companies
![](/sites/default/files/styles/article_actu_main_image/public/2023-09/actu-malaisie.jpg?itok=6JGZzXaH)
Opening will enable pharmaceutical company to better provide UK market with direct distribution and client-facing team. UK third direct-selling country for Provepharm, after France and the United States, expanding commercial presence in medical dye and antidote markets
![](/sites/default/files/styles/article_actu_main_image/public/2023-09/actu-rse.jpg?itok=Hj9Nb2e8)
In 2022, Provepharm reached an important milestone in its CSR strategy. In this "2023 CSR Impact", the essential elements of our approach have been grouped together.
![](/sites/default/files/styles/article_actu_main_image/public/2023-09/actu-malaisie.jpg?itok=6JGZzXaH)
Provepharm, an international, private and sustainable pharmaceutical company specialized in revitalizing molecules and Pharm-D, a healthcare and pharmaceutical company based in Malaysia with a strong foothold in Singapore, announce today their partnership to launch Proveblue® 5 mg/ml solution for injection in Malaysia.